UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 3, 2024 4:30 P.M.
Form:
S-3
CIK:
0001806952
Company Name:
Lyell Immunopharma, Inc.
File Number:
333-277495